The cGAS-STING pathway, which facilitates tumor-immune cell crosstalk by activating antigen-presenting cells such as dendritic cells through tumor-derived DNA, triggers immune responses, including type I IFN secretion, tertiary lymphoid structure formation, and enhanced antitumor responses by T cells and NK cells. Here, STING1 is linked to neoplasm.